BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhubanchaliyev A, Temirbekuly A, Kongrtay K, Wanshura LC, Kunz J. Targeting Mechanotransduction at the Transcriptional Level: YAP and BRD4 Are Novel Therapeutic Targets for the Reversal of Liver Fibrosis. Front Pharmacol 2016;7:462. [PMID: 27990121 DOI: 10.3389/fphar.2016.00462] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Fu X, Chang J, Jiao D, Zhu M, Ma Y. SLIT3 knockdown inhibited TGF-β-induced hepatic stellate cells activation by down-regulating YAP signal. Mol Cell Toxicol 2023. [DOI: 10.1007/s13273-023-00336-3] [Reference Citation Analysis]
2 Yang Z, Liu Y, Cheng Q, Chen T. Targeting super enhancers for liver disease: a review. PeerJ 2023;11:e14780. [PMID: 36726725 DOI: 10.7717/peerj.14780] [Reference Citation Analysis]
3 Nokkeaw A, Thamjamrassri P, Tangkijvanich P, Ariyachet C. Regulatory Functions and Mechanisms of Circular RNAs in Hepatic Stellate Cell Activation and Liver Fibrosis. Cells 2023;12. [PMID: 36766720 DOI: 10.3390/cells12030378] [Reference Citation Analysis]
4 Zhang C, Han X, Xu J, Jiang M, Zhou Y. Matrix stiffness-induced transcriptome alterations and regulatory mechanisms revealed by RNA-seq in Endothelial cells.. [DOI: 10.21203/rs.3.rs-2016915/v1] [Reference Citation Analysis]
5 Kitsugi K, Noritake H, Matsumoto M, Hanaoka T, Umemura M, Yamashita M, Takatori S, Ito J, Ohta K, Chida T, Ulmasov B, Neuschwander-Tetri BA, Suda T, Kawata K. Arg-Gly-Asp-binding integrins activate hepatic stellate cells via the hippo signaling pathway. Cell Signal 2022;99:110437. [PMID: 35970425 DOI: 10.1016/j.cellsig.2022.110437] [Reference Citation Analysis]
6 Paul S, Xie S, Yao X, Dey A. Transcriptional Regulation of the Hippo Pathway: Current Understanding and Insights from Single-Cell Technologies. Cells 2022;11:2225. [PMID: 35883668 DOI: 10.3390/cells11142225] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhang C, Han X, Xu J, Zhou Y. Matrix Stiffness-Induced Transcriptome Alterations and Regulatory Mechanisms Revealed by RNA-Seq in Endothelial Cells. JBNB 2022;13:61-79. [DOI: 10.4236/jbnb.2022.133004] [Reference Citation Analysis]
8 Yeh CF, Chou C, Yang KC. Mechanotransduction in fibrosis: Mechanisms and treatment targets. Curr Top Membr 2021;87:279-314. [PMID: 34696888 DOI: 10.1016/bs.ctm.2021.07.004] [Reference Citation Analysis]
9 Passi M, Zahler S. Mechano-Signaling Aspects of Hepatocellular Carcinoma. J Cancer 2021;12:6411-21. [PMID: 34659531 DOI: 10.7150/jca.60102] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Jung H, Chen J, Hu X, Sun H, Wu SY, Chiang CM, Kemper B, Chen LF, Kemper JK. BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination. JCI Insight 2020;6:141640. [PMID: 33290278 DOI: 10.1172/jci.insight.141640] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
11 Miao H, Wu XQ, Zhang DD, Wang YN, Guo Y, Li P, Xiong Q, Zhao YY. Deciphering the cellular mechanisms underlying fibrosis-associated diseases and therapeutic avenues. Pharmacol Res 2021;163:105316. [PMID: 33248198 DOI: 10.1016/j.phrs.2020.105316] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
12 Tirella A, Mattei G, La Marca M, Ahluwalia A, Tirelli N. Functionalized Enzyme-Responsive Biomaterials to Model Tissue Stiffening in vitro. Front Bioeng Biotechnol 2020;8:208. [PMID: 32322576 DOI: 10.3389/fbioe.2020.00208] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
13 El-Derany MO. Polymorphisms in Interleukin 13 Signaling and Interacting Genes Predict Advanced Fibrosis and Hepatocellular Carcinoma Development in Non-Alcoholic Steatohepatitis. Biology (Basel) 2020;9:E75. [PMID: 32283835 DOI: 10.3390/biology9040075] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
14 Haaker MW, Vaandrager AB, Helms JB. Retinoids in health and disease: A role for hepatic stellate cells in affecting retinoid levels. Biochim Biophys Acta Mol Cell Biol Lipids 2020;1865:158674. [PMID: 32105672 DOI: 10.1016/j.bbalip.2020.158674] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
15 Ishida S. Requirements for designing organ-on-a-chip platforms to model the pathogenesis of liver disease. Organ-on-a-chip 2020. [DOI: 10.1016/b978-0-12-817202-5.00005-x] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
16 Wang S, Yu J, Kane MA, Moise AR. Modulation of retinoid signaling: therapeutic opportunities in organ fibrosis and repair. Pharmacol Ther 2020;205:107415. [PMID: 31629008 DOI: 10.1016/j.pharmthera.2019.107415] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
17 Han I, Thakor DK, Ropper AE, Yu D, Wang L, Kabatas S, Zeng X, Kim S, Zafonte RD, Teng YD. Physical impacts of PLGA scaffolding on hMSCs: Recovery neurobiology insight for implant design to treat spinal cord injury. Experimental Neurology 2019;320:112980. [DOI: 10.1016/j.expneurol.2019.112980] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
18 Yamanishi C, Robinson S, Takayama S. Biofabrication of phenotypic pulmonary fibrosis assays. Biofabrication 2019;11:032005. [PMID: 31215521 DOI: 10.1088/1758-5090/ab2286] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
19 Fernández-Colino A, Iop L, Ventura Ferreira MS, Mela P. Fibrosis in tissue engineering and regenerative medicine: treat or trigger? Adv Drug Deliv Rev 2019;146:17-36. [PMID: 31295523 DOI: 10.1016/j.addr.2019.07.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
20 Lachowski D, Cortes E, Rice A, Pinato D, Rombouts K, Del Rio Hernandez A. Matrix stiffness modulates the activity of MMP-9 and TIMP-1 in hepatic stellate cells to perpetuate fibrosis. Sci Rep 2019;9:7299. [PMID: 31086224 DOI: 10.1038/s41598-019-43759-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 12.5] [Reference Citation Analysis]
21 Manmadhan S, Ehmer U. Hippo Signaling in the Liver - A Long and Ever-Expanding Story. Front Cell Dev Biol 2019;7:33. [PMID: 30931304 DOI: 10.3389/fcell.2019.00033] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 11.8] [Reference Citation Analysis]
22 Cortes E, Lachowski D, Rice A, Chronopoulos A, Robinson B, Thorpe S, Lee DA, Possamai LA, Wang H, Pinato DJ, Del Río Hernández AE. Retinoic Acid Receptor-β Is Downregulated in Hepatocellular Carcinoma and Cirrhosis and Its Expression Inhibits Myosin-Driven Activation and Durotaxis in Hepatic Stellate Cells. Hepatology 2019;69:785-802. [PMID: 30055117 DOI: 10.1002/hep.30193] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 9.3] [Reference Citation Analysis]
23 Smith SA, Sessions RB, Shoemark DK, Williams C, Ebrahimighaei R, McNeill MC, Crump MP, McKay TR, Harris G, Newby AC, Bond M. Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking. J Med Chem 2019;62:1291-305. [PMID: 30640473 DOI: 10.1021/acs.jmedchem.8b01402] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 11.8] [Reference Citation Analysis]
24 Lee EH, Park KI, Kim KY, Lee JH, Jang EJ, Ku SK, Kim SC, Suk HY, Park JY, Baek SY, Kim YW. Liquiritigenin inhibits hepatic fibrogenesis and TGF-β1/Smad with Hippo/YAP signal. Phytomedicine 2019;62:152780. [PMID: 31121384 DOI: 10.1016/j.phymed.2018.12.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
25 Walraven M, Hinz B. Therapeutic approaches to control tissue repair and fibrosis: Extracellular matrix as a game changer. Matrix Biology 2018;71-72:205-24. [DOI: 10.1016/j.matbio.2018.02.020] [Cited by in Crossref: 110] [Cited by in F6Publishing: 98] [Article Influence: 22.0] [Reference Citation Analysis]
26 Zent J, Guo LW. Signaling Mechanisms of Myofibroblastic Activation: Outside-in and Inside-Out. Cell Physiol Biochem 2018;49:848-68. [PMID: 30184544 DOI: 10.1159/000493217] [Cited by in Crossref: 63] [Cited by in F6Publishing: 70] [Article Influence: 12.6] [Reference Citation Analysis]
27 Qu M, Zhang X, Hu X, Dong M, Pan X, Bian J, Zhou Q. BRD4 inhibitor JQ1 inhibits and reverses mechanical injury-induced corneal scarring. Cell Death Discov 2018;4:5. [PMID: 30062054 DOI: 10.1038/s41420-018-0066-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
28 Amicone L, Marchetti A. Microenvironment and tumor cells: two targets for new molecular therapies of hepatocellular carcinoma. Transl Gastroenterol Hepatol 2018;3:24. [PMID: 29971255 DOI: 10.21037/tgh.2018.04.05] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 5.8] [Reference Citation Analysis]
29 Du K, Hyun J, Premont RT, Choi SS, Michelotti GA, Swiderska-Syn M, Dalton GD, Thelen E, Rizi BS, Jung Y, Diehl AM. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells. Gastroenterology 2018;154:1465-1479.e13. [PMID: 29305935 DOI: 10.1053/j.gastro.2017.12.022] [Cited by in Crossref: 151] [Cited by in F6Publishing: 153] [Article Influence: 30.2] [Reference Citation Analysis]
30 Li XQ, Ren ZX, Li K, Huang JJ, Huang ZT, Zhou TR, Cao HY, Zhang FX, Tan B. Key Anti-Fibrosis Associated Long Noncoding RNAs Identified in Human Hepatic Stellate Cell via Transcriptome Sequencing Analysis. Int J Mol Sci 2018;19:E675. [PMID: 29495545 DOI: 10.3390/ijms19030675] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
31 Mazza G, Al-Akkad W, Rombouts K. Engineering in vitro models of hepatofibrogenesis. Adv Drug Deliv Rev 2017;121:147-57. [PMID: 28578016 DOI: 10.1016/j.addr.2017.05.018] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
32 de Oliveira da Silva B, Ramos LF, Moraes KCM. Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis. Cell Biol Int 2017;41:946-59. [PMID: 28498509 DOI: 10.1002/cbin.10790] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]